share_log
Reuters ·  May 1 08:04
Cocrystal Pharma: Plans Phase 1 Study in Australia With Inhaled Formulation of Cc-42344 as Potential Influenza a Treatment & Post-Exposure Prophylaxis
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment